NEW DELHI:India has risen to 8th position globally from 123rd in the World Health Organization’s (WHO) pharmacovigilance contributions, said Union Minister for Health and Family Welfare J. P. Nadda on Friday.
He was speaking at the release of the Indian Pharmacopoeia 2026 (IP 2026) - the 10th edition of India’s official book of drug standards, at an event held at the Dr. Ambedkar International Centre, New Delhi.
“The Indian Pharmacopoeia serves as the official book of standards for drugs in the country and is a cornerstone of India’s regulatory framework for pharmaceuticals, ” he said, adding that the 10th edition reflects scientific advancements, global best practices, and India’s growing leadership in pharmaceutical manufacturing and regulation.
Nadda also highlighted the remarkable progress of the Pharmacovigilance Programme of India (PvPI) under the Indian Pharmacopoeia Commission (IPC).